Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Reprocessing Under New EU Regulations Puts Burden On Commission

This article was originally published in SRA

Executive Summary

Reprocessing and further use of single-use medical devices in the EU will only be able to take place when permitted by national law, according to the texts of the new EU regulations for devices and IVDs, which were agreed by the Council of the European Union and the European Parliament on May 25, and made publicly available this week1. In addition, if the national law allows it, then those who reprocess must meet the requirements laid down in the Medical Device Regulation, once the legislation is adopted.

You may also be interested in...



EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency

Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.

First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve

Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.

First Danish Notified Body Named Under EU's Medical Device Regulation

The EU now has a total of 45 notified bodies under the MDR.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel